Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Semaxanib |
Trade Name | |
Synonyms | SU5416|Semoxind|Sugen 5416 |
Drug Descriptions |
Semaxanib (SU5416) is an inhibitor of FLT1 (VEGFR1), KDR (VEGFR2), and FLT3, which inhibits tumor vascularization and growth (PMID: 9892193, PMID: 12351406, PMID: 29208523). |
DrugClasses | FLT3 Inhibitor 69 VEGFR1 Inhibitor 6 VEGFR2 Inhibitor 37 |
CAS Registry Number | 194413-58-6 |
NCIT ID | C1831 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Semaxanib | Semaxanib | 1 | 0 |